Insights

Thought Leadership

COVID-19 HUB

COVID-19 HUB

Our COVID-19 HUB is designed to keep our stakeholders updated and help them understand the legal effects of COVID-19 outbreak, and take steps to maintain their businesses in Turkey.

Commercial Dispute Resolution Under Turkish Law Rules, Developments and Insights - 2020

Commercial Dispute Resolution Under Turkish Law Rules, Developments and Insights - 2020

Commercial Dispute Resolution under Turkish Law: Rules, Developments and Insights

Patent Law in Turkey Key Developments and Predictions - 2020

Patent Law in Turkey Key Developments and Predictions - 2020

In this year's report, we focus on the key aspects of patent litigation in Turkey, and the most important or challenging issues in Turkish Patent Law.

Trademark Law in Turkey Key Developments and Predictions - 2020

Trademark Law in Turkey Key Developments and Predictions - 2020

In this year's report, we focus on the eight main challenges encountered in the interpretation and implementation of key changes introduced by the IP Code.

Copyright Law in Turkey Key Developmentr and Predictions

Copyright Law in Turkey Key Developmentr and Predictions

In the report, we outline seven controversial issues that we often encounter in Turkish copyright Law.

Life Sciences Law in Turkey Key Developments and Predictions - 2020

Life Sciences Law in Turkey Key Developments and Predictions - 2020

In this year's report, we focus on the key aspects of life sciences in Turkey, the most important and challenging issues in Turkey’s life sciences industry.

Media and Advertising Law in Turkey Key Developments and Predictions - 2020

Media and Advertising Law in Turkey Key Developments and Predictions - 2020

In this year's report, we focus on the key aspects of media and advertising law in Turkey, and the most important or challenging issues in Turkish media and advertising Law.

View all

Monthly Newsletters

July 2020

July 2020

We are pleased to publish our monthly newsletters to update our community and clients about legal developments in Turkey.

View all issues
Subscribe

Key Developments and Predictions for Patent Law in Turkey – 2020

Articles -
IP Prosecution, Intellectual Property and Patent and Utility Models || Gün + Partners

It has been three years since the Industrial Property Law, which combined different Decree Laws on specific IP rights, came into force. The fourth book of the Law introduces relatively new provisions regarding the patent system in Turkey that bring the national law into line with the European Patent Convention (EPC). Although it is too early for the implications of the new law to have come to light, working requirements and compulsory licensing remain the most questioned topi...»

Declaration of Use and Compulsory License

Articles -
IP Prosecution, Intellectual Property and Patent and Utility Models || Gün + Partners

The new IP Law (the “Law”) numbered 6769 abolished the provisions on “the use requirement of patents,” and “the evidence of use” of the Decree Law Pertaining to the Protection of Patent Rights. The Law now focuses on the requirements of use for patents within the provision of a Compulsory License. Accordingly, a patent owner must make use of the patented invention within three years following publication of its granted decision in the Official Bulletin (‘the Bulletin’) or wit...»

Difficulties of Enforcing Patent Rights on NPP Products

Articles -
IP Prosecution, Intellectual Property and Patent and Utility Models || Gün + Partners

The supply of pharmaceutical products to Turkey via the named patient programme (the “NPP”) is one of the exceptional importation regimes for pharmaceutical products. Where a pharmaceutical product is not granted marketing authorisation in Turkey, but patients are in need of it, it can be supplied via this special route. The entities that are authorised to import pharmaceuticals within the scope of the NPP are the Turkish Pharmacists’ Association (the “TEB”) and the Ibn-i Sin...»

Ex Parte Injunctions in Turkish IP Law

Articles -
IP Prosecution, Intellectual Property and Patent and Utility Models || Gün + Partners

Although ex parte injunctions are legally available, are quite rare in Turkish Patent Law practice. The IP Courts almost always reject requests for ex parte injunctions, preferring to evaluate the alleged infringement only after hearing both parties. However, in 2019, the Turkish IP Court unexpectedly granted a request for an ex parte injunction, due to the urgent nature of the matter. The request for this ex parte injunction was filed against a company in Argentina. The comp...»

Discovery of Evidence Is Not Subject to Bolar Exemption

Articles -
IP Prosecution, Intellectual Property and Patent and Utility Models || Gün + Partners

Discovery of evidence and actions for determination of evidence are separately regulated under the Civil Procedural Law. Discovery of evidence is a preliminary step taken before any action on the merits, and it only serves to discover and record the evidence that may be relevant to an ongoing or future action on the merits. It must be emphasised that unlike the US and UK systems, there is no full and frank disclosure procedure under Turkish civil law. In other words, the part...»

Impact of EPO Opposition on National Actions

Articles -
IP Prosecution, Intellectual Property and Patent and Utility Models || Gün + Partners

Since Turkey’s inclusion as a member of the EPC, a hot topic has been the enforcement or invalidity of Turkish validation of European Patent(s) (“EP”) while proceedings before the European Patent Office (the “EPO”) are pending. Once an EP is validated in Turkey, it becomes a national patent three months after its first granted decision by the Examination Board of the EPO. For EPs, the Turkish Patent and Trademark Office (the “TPMO”) acts only as a procedural agency. Thus, the...»

2nd Damages Judgment in the Pharma Sector for Unjust PI

Articles -
IP Prosecution, Intellectual Property and Patent and Utility Models || Gün + Partners

In 2018, the Istanbul IP Court decided on a generic pharmaceutical company’s damages claim based on an unjust PI, in what appears to be the first decision of its kind by the Turkish IP Courts within the pharmaceutical sector. The dispute between an originator firm and a generic firm derived from an infringement claim. The Court had issued a PI, which was lifted after 13 months based on the findings of an expert’s report, which found that no infringement had been made. The gen...»

New Guidelines on Named Patient Programme

Articles -
Life Sciences || Dicle Doğan and Fatma Sevde Tan

In Turkey, the law explicitly states that pharmaceuticals which have their safety and efficacy proven through sufficient scientific and clinical studies within the direction of existing treatment guides, and are granted market authorisation by the Turkish Medicines and Medical Devices Agency (“Agency”) must be supplied only by pharmacies. However, the Agency is also competent to determine the exceptional importation regimes. Named Patient Program (“NPP”) is one of the excepti...»

EC Certificates' Status During Transition Period for Brexit

Articles -
Life Sciences || Dicle Doğan and Fatma Sevde Tan

Dicle Doğan and Fatma Sevde Tan, Gun + Partners On 1 February 2020, the Presidential Circular No 2020/1 was published on the Official Gazette No 31026 on the transition period for the UK's exit from the EU. The circular indicated that the UK will continue to be subject to EU law until 31 December 2020. Upon the publication of the Circular, the Turkish Medicines and Medical Devices Agency published an announcement (Turkish language) about the effects of this transition period...»

Consultation on New Draft Regulation on Promotion of Medical Devices

Articles -
Life Sciences || Dicle Doğan and Fatma Sevde Tan

Dicle Doğan and Fatma Sevde Tan, Gun + Partners On 28 January 2020, the Turkish Medicines and Medical Devices Agency published a draft Regulation on the Sale, Advertisement and Promotion of Medical Devices (Turkish language) which will amend some of the existing provisions of the regulatory framework and introduce new rules. The most significant amendments are related to restrictions of medical device sales and advertising activities. The medical devices described in either o...»

DERBY Case: Court of Appeal Overturns Lowercourt Decisions in Controversial Ruling

Articles -
Trademarks and Designs || Güldeniz Doğan Alkan and Dilan Sıla Kayalıca

In opposition proceedings, the Court of Appeal has found that there was copyright infringement since the opponent’s logo had been copied in the mark applied for The well-known status of the earlier mark also served as a basis for the decision Arguably, the court correctly found that the applicant’s trademark should not be registered, but erred in its reasoning Background The owner of the DERBY trademark, registered and well known for razor blades, opposed an application for...»

Turkish Appeal Court Rules in Cow Trade Mark Case

Articles -
Trademarks and Designs || Güldeniz Doğan Alkan and Dilan Sıla Kayalıca

In a case concerning trade mark and copyright law, the Turkish Court of Appeal has ruled that the use of a figure intensively cannot prevent the use of similar figures, as long as they are not identical. Background A recent decision of the Court of Appeal concerned an application to register a trade mark (shown right) in classes 29 and 43. The word elements in this application can be considered of low distinctiveness: ET means “meat” in Turkish, and so is descriptive for som...»